The new combined formulation will be delivered using a breath-actuated nebuliser. Currently, AeroRx is said to be engaged in the development of the first nebulised LABA/LAMA combination solution The post AeroRx, HCmed to develop nebulised combination formulation for COPD appeared first on Pharmaceutical Business review.

In preclinical studies, AT-752 showed potent activity against all dengue serotypes.

The company is seeking approval for tukysa and trastuzumab combination for the treatment of HER2-positive colorectal cancer in adult patients who have received at least one treatment regimen The post FDA accepts for priority review Seagen’s sNDA for colorectal cancer medicine appeared first on Pharmaceutical Business review.

How Data Shapes the Future of Omnichannel Marketing

As healthcare marketers strive to keep pace with data technologies for better targeting and conversion, budgeting for 2019 becomes a formidable challenge. Questions about competitive advantages and cost-effectiveness drive conversations. Yet, the focus of forward-thinkers is shifting to better data for targeting faster and sooner in the engagement lifecycle. “We are seeing a dramatic increase in ...

PharmaLeaders is pleased to provide our subscribers with a special offer from our webinar partner and presenter, Collaborative Marketing Solutions (CMS). Get your own Marketing Tech Workshop for Life Sciences:  Full Day or Half Day Sessions Facilitated Exercises & Group Breakout Sessions Customer Segmentation Project Prioritization Project Implementation Roadmap Follow-on Kick-off Call